Omnipod: Alternate controller enabled insulin infusion pump — FDA announcement Mar 13, 2026

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Mar 13, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Alternate controller enabled insulin infusion pump
Reason
Pods may have a small tear in the internal tubing that delivers insulin. This may leak inside the Pod instead of being fully infused into the body as intended.
Classification
Not supplied
Recalling firm
Insulet Corporation
Quantity
Not supplied
Agency-reported status
Company recall announcement
Source record identifier
914430f969aed6ea

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityCustomers can visit omnipod.com/check-pods to check lot numbers and request replacement Pods at no cost; Customers should visit omnipod.com/check-pods to confirm whether their Pod lot number is included in this voluntary Medical Device Correction and request replacement Pods at no cost.; If a Pod from an affected lot is currently in use, customers should discontinue use and replace it with a Pod from an unaffected lot.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date
Mar 13, 2026
Company announcement date
Mar 12, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records